Introduction
============

Since its inception, vessel sealing with ultrasonic devices has been recognized as having many advantages over conventional electrosurgery.[@b1-mder-6-151] The purely mechanical action of the ultrasonic end effector eliminates the passage of any current to or through the patient, reducing the risk of nerve damage.[@b2-mder-6-151] Hemostasis is achieved with minimal lateral thermal damage,[@b3-mder-6-151] and minimal smoke (mist or vapor) is produced.[@b4-mder-6-151]

Critical to the formation of a strong and durable vessel seal is the energy profile delivered by an ultrasonic device. Building on the foundation of basic Harmonic® functionality, Adaptive Tissue Technology has been developed to provide greater precision through improved energy delivery.[@b5-mder-6-151] Exclusive to Harmonic devices, Adaptive Tissue Technology actively monitors the instrument during use and enables the system to respond intelligently to varying tissue conditions. With the Harmonic ACE®+ Shears (Ethicon Endo-Surgery, Inc., Cincinnati, OH, USA; [Figure 1](#f1-mder-6-151){ref-type="fig"}), Adaptive Tissue Technology delivers greater precision by regulating energy delivery when needed. During a transection and as tissue divides, the blade contacts the tissue pad of the device and the blade temperature typically begins to increase more rapidly. Adaptive Tissue Technology responds by reducing the power output and providing enhanced feedback with a change in an audible activation tone. Hemostasis is achieved and unnecessary power output that could potentially lead to thermal injury is reduced. Additionally, the Harmonic ACE+ Shears feature a tapered, coated blade that brings precision to multiple surgical jobs, including dissection, sealing, transection, and grasping.

This study was undertaken to compare the Harmonic ACE+ Shears with Adaptive Tissue Technology, with the previous version of the Harmonic ACE® Shears (Ethicon Endo-Surgery, Inc.,). It was hypothesized that the technological advances incorporated into the new device would maintain rates of initial hemostasis and seal durability, while decreasing transection time, thermal damage, smoke formation, and the risk of adhesion formation during wound healing.

Methods
=======

All procedures were reviewed and the animals approved for use in the study by the Ethicon Endo-Surgery Institutional Animal Care and Use Committee. A porcine model was chosen based on the similarity of its blood vessel composition and sealing to that of humans.

The primary comparison was between Harmonic ACE Shears of lengths 23 and 36 cm, and the new Harmonic ACE+ Shears with Adaptive Tissue Technology of the same lengths. For the acute procedures, both the 23 and 36 cm lengths of the new and predicate devices were utilized and compared; for the survival study, the 36 cm lengths of each were utilized and compared.

Vessel sealing was tested for ACE versus ACE+ in porcine carotid, gastroepiploic, splenic, and short gastric arteries, veins and pedicles, at generator power level settings of 3 or 5. Intraoperative measurements included vessel size, transection time, initial hemostasis, and tissue sticking. Postoperatively, thermal damage was assessed via hematoxylin and eosin (H&E) staining. A subset of the animals was allowed to survive up to 30 days, at which time hemostasis was checked at each vessel seal after raising the blood pressure to \>200 mmHg to induce a simulated hypertensive crisis. At necropsy, a visual examination for adhesions was also performed.

Burst pressures were measured on porcine carotid vessels of diameter 3--5 mm sealed with ACE (n = 80) or ACE+ (n = 80) at power level 3, via injection of saline at a rate of 26 mL/min using a proprietary system.

Visual obstruction from smoke or haze was measured by a conventional method.[@b6-mder-6-151] In a specially constructed chamber, the devices were activated for 3 seconds on the maximum power setting, which was considered a worst-case scenario. Five devices each of ACE and ACE+ were used, and 12 runs were performed per device. The curved version of each device was used, as this represents the worst-case scenario for plume generation, since curved blades produce turbulent plume flow, whereas straight blades produce laminar flow. Obstruction was recorded using a Tele Pack X system with a Telecam camera (Karl Storz GmbH and Co, KG, Tuttlingen, Germany). The recording was converted with Movavi® Video Converter software, version 12 (Movavi, Saint Louis, MO, USA) and analyzed with ImageJ image processing and analysis software, version 1.48b (National Institutes of Health, Bethesda, MD, USA) to measure the amount of pixel obstruction observed in real-time.

Continuous variables, such as transection time or thermal damage, were compared using a *t*-test or analysis of covariance (ANCOVA), as appropriate, and binomial variables, such as hemostasis and adhesions, were compared using Fisher's exact test.

Results
=======

There were no complications during the acute procedures and all but one animal in the 30-day study survived until the appointed time. A single animal was found deceased after 18 days due to unrelated causes; all vessel seals were healing normally with no evidence of bleeding.

The distribution of vessel types used was not significantly different between ACE and ACE+. The diameters of vessels ranged from 1 to 5 mm, and the mean vessel diameter was 3.4 mm for both devices. There was no difference in the distribution of generator power settings used between the two devices.

A tabulation of key results is given in [Table 1](#t1-mder-6-151){ref-type="table"}. Initial hemostasis was high for both devices (97.7% for ACE and 99.0% for ACE+) and not significantly different. The new Harmonic ACE+ Shears were 21% faster (*P* \< 0.001) in transection time than the predicate shears. Neither device exhibited any tissue sticking. As measured by H&E staining, the mean zone of adventitial collagen denaturation (thermal damage) for ACE+ was \<2 mm, and 23% less than ACE (*P* \< 0.001; [Figure 2](#f2-mder-6-151){ref-type="fig"}).

At the end of the survival period, both devices showed 100% hemostasis of all seals after a simulated hypertensive crisis \>222 mmHg. The predicate device, ACE, had adhesion formation at 39.4% of vessel seals, while the new ACE+ had no adhesion formation at any site (*P* \< 0.001).

Burst pressures from ex vivo testing were significantly higher for ACE+ than for ACE (*P* = 0.002). Visual obstruction from smoke/mist was reduced by 40.5% for ACE+ compared with ACE (*P* \< 0.001).

Discussion
==========

In the preclinical study reported here, we examined the effects of incorporation of Adaptive Tissue Technology into the Harmonic platform. This technology provides the system with the ability to monitor the thermal condition of the blade and to identify conditions correlative to unnecessary thermal energy -- namely, rapid increases in heat flux into the blade from action directly against the tissue pad rather than against tissue. When minimal tissue remains in the jaw, the generator decreases its power output and an audible change in tone provides enhanced feedback to the user. This more intelligent technology reduces unnecessary power application that could potentially lead to excess thermal injury.

Historically, Harmonic ACE Shears have been shown to provide excellent hemostasis,[@b7-mder-6-151] and strong, durable seals.[@b8-mder-6-151] In the current study, we observed that the Harmonic ACE+ Shears maintain these properties, with 99% success in initial hemostasis in vessels up to 5 mm diameter, and 100% durability of vessel seals up to 30 days postoperatively. Burst pressures for ACE+ were 25% higher than for ACE, although blade temperatures were significantly lower.

In contrast with electrosurgical methods, ultrasonic devices are recognized as producing less tissue sticking during use.[@b9-mder-6-151] The improvements in ACE+ were shown in this study to maintain this useful characteristic, critical to operational speed and efficiency, with no observed tissue sticking. ACE+ produced less smoke and visual obstruction, which can also lead to increased operation efficiency.

The Harmonic ACE+ Shears transected tissue 21% faster than the previous model. This significant difference is in part due to thermal monitoring and enhanced audible feedback to the user. Based on the lower temperatures produced by ultrasonic devices, it has been shown that they produce less thermal damage than electrosurgical devices,[@b10-mder-6-151] and that the reduced thermal damage has resulted in less inflammation[@b11-mder-6-151] and faster wound healing.[@b12-mder-6-151] With ACE+, the improved energy management has further reduced the thermal damage, leading to a 23% decrease and a mean zone of collagen denaturation \<2 mm.

The inflammatory reaction due to collagen denaturation has been implicated in postoperative adhesion formation.[@b13-mder-6-151] The decreased thermal damage caused by ACE+ may be responsible for the reduced rate of adhesion formation compared with that of the previous version of the device. It is also possible that the coated blade aids in the prevention of adhesions. In any case, no adhesions were observed after a 30-day survival period with ACE+ in this preclinical model.

Conclusion
==========

The new Harmonic ACE+ Shears continue to provide excellent vessel sealing hemostasis and durability, with no tissue sticking. Incorporation of Adaptive Tissue Technology has optimized the delivery of energy to provide enhanced precision, resulting in reduced tissue damage, faster dissection, better procedure visualization, and lowered risk of postoperative adhesion formation.
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![End effector of the harmonic ACE®+ Shears (Ethicon Endo-Surgery, Inc., Cincinnati, OH, USA).](mder-6-151Fig1){#f1-mder-6-151}

![Mean thermal damage via hematoxylin and eosin (H&E) for ACE® and ACE®+; ACE+ had a significantly narrower band of thermal damage than ACE.\
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###### 

ACE® versus ACE®+ results summary

  Measure                                                       ACE          ACE+         *P*-value
  ------------------------------------------------------------- ------------ ------------ -----------
  Transection time[\*](#tfn1-mder-6-151){ref-type="table-fn"}   5.7 s        4.5 s        \<0.001
  Initial hemostasis                                            127/130      95/96        0.639
  Thermal damage[\*\*](#tfn2-mder-6-151){ref-type="table-fn"}   2.19 mm      1.69 mm      \<0.001
  Survival hemostasis                                           33/33        32/32        1.000
  Adhesions                                                     13/33        0/32         \<0.001
  Burst pressure                                                1,208 mmhg   1,514 mmhg   0.002
  Average visual obstruction                                    4.57%        2.72%        \<0.001

**Notes:**

Adjusted for vessel size and device length via analysis of covariance (ANCOVA);

adjusted for device length and vessel type via ANCOVA.
